Advertisement

Drug selectivity in the suppression of the immune response

  • E. Mihich
Part of the Biological Council Co-ordinating Committee for Symposia on Drug Action book series (BCSDA)

Abstract

Chemotherapy is a relatively effective treatment for certain types of neoplastic diseases. In fact, by using drugs alone or in combination, good quality life can be prolonged and, in some cases, complete remission can be obtained with no evidence of the disease being found five years or more after diagnosis. These therapeutic results are obtained in patients with certain types of choriocarcinoma, Wilm’s tumour, Burkitt’s lymphoma, acute lymphocytic leukaemia and certain tumours of the skin. In the near future, chemotherapeutic treatments in conjunction with surgery may provide additional examples of therapeutic efficacy, as in the case of osteogenic sarcoma of the limb and of pre-menopausal breast tumours.

Keywords

Spleen Cell Selective Effect Immunise Mouse Dihydrofolate Reductase Drug Selectivity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson, R., Glover, A., Koornhof, H. J. and Rabson, A. R. (1976). J. Immun., 117, 428Google Scholar
  2. Avery, W. K. (1976). Ann. N. Y. Acad. Sci., 277, 260CrossRefGoogle Scholar
  3. Bennett, J., Ehrke, J., Dave, C. and Mihich, E. (1977). Biochem. Pharmac., 26, 723CrossRefGoogle Scholar
  4. Bennett, J., Ehrke, J., Fadale, P., Dave, C. and Mihich, E. (1978). Biochem. Pharmac., (in press)Google Scholar
  5. Berenbaum, M. C. (1964). Lancet, ii, 1363CrossRefGoogle Scholar
  6. Berenbaum, M. C. and Brown, I. N. (1965). Immunology, 8, 251Google Scholar
  7. Bertino, J. R. (1975). In Antineoplastic and Immunosuppressive Agents II, (eds. A. C. Sartorelli and D. G. Johns), Springer-Verlag, New YorkGoogle Scholar
  8. Chanmougan, D. and Schwartz, R. S. (1966). J. exp. Med., 124, 363CrossRefGoogle Scholar
  9. Cohen, S. A., Ehrke, M. J. and Mihich, E. (1975). J. Immun., 115, 1007Google Scholar
  10. Corti, A., Dave, C., Williams-Ashman, H. G., Mihich, E. and Schenone, A. (1974). Biochem. J., 139, 351CrossRefGoogle Scholar
  11. Creasey, W. A. (1975). In Antineoplastic and Immunosuppressive Agents II, (eds. A. C. Sartorelli and D. G. Johns), Springer-Verlag, New YorkGoogle Scholar
  12. Dave, C. and Mihich, E. (1972). Biochem. Pharmac., 21, 2681CrossRefGoogle Scholar
  13. Ehrke, M. J., Cohen, S. A. and Mihich, E. (1978). Cancer Res., 38, 521Google Scholar
  14. Frei, E. III, Jaffe, N., Tattersall, M. H. N., Pitman, S. and Parker, L. (1975). New Engl. J. Med., 292, 846CrossRefGoogle Scholar
  15. Friedman, R. M., Baron, S. and Buckler, C. (1962). Blood, 20, 115Google Scholar
  16. Gerebtzoff, A., Lambert, P. H. and Miescher, P. A. (1972). A. Rev. Pharmac., 12, 287CrossRefGoogle Scholar
  17. Glynn, J. P., Bianco, A. R. and Goldin, A. (1963). Nature, 198, 1003CrossRefGoogle Scholar
  18. Goldin, A. and Mantel, N. (1957). Cancer Res., 17, 635Google Scholar
  19. Griswold, D. E., Heppner, G. H. and Calabresi, P. (1972). Cancer Res., 32, 298Google Scholar
  20. Hakala, M. T., Slocum, H. K. and Gryko, G. J. (1975). J. cell. Physiol., 86, 281CrossRefGoogle Scholar
  21. Heppner, G. H. and Calabresi, P. (1972). J. natn. Cancer Inst., 48, 1161Google Scholar
  22. Hersey, P. (1973). Transplantation, 15, 282CrossRefGoogle Scholar
  23. Hersh, E. M. (1973). In Cancer Medicine, (eds. J. F. Holland and E. Frei III ), Lea and Febiger, PhiladelphiaGoogle Scholar
  24. Hersh, E. M. (1974). In Antineoplastic and Immunosuppressive Agents I, (eds. A. C. Sartorelli and D. G. Johns), Springer-Verlag, New YorkGoogle Scholar
  25. Hoffmann, C. C., Ehrke, M. J. and Mihich, E. (1978). Proc. Am. Ass. Cancer Res., 19, 221Google Scholar
  26. Jerne, N. K. and Nordin, AA. (1963). Science, 140, 405CrossRefGoogle Scholar
  27. Klein, G. (1966). A. Rev. Microbiol., 20, 223CrossRefGoogle Scholar
  28. Levin, R. H., Henderson, E., Koryn, M. and Freireich, E. J. (1965). Clin. Pharmac. Ther., 6, 31Google Scholar
  29. Levitt, M., Mosher, M. B., DeConti, R. C., Farber, L. R., Skeel, R. T., Marsh, J. C., Mitchell, M. S., Papac, R. J., Thomas, E. D. and Bertino, J. R. (1973). Cancer Res., 33, 33, 1729Google Scholar
  30. Lochte, H. L. Jr., Levy, A. S., Guenther, D. M., Thomas, E. D. and Ferrebee, J. W. (1962). Nature, 196, 1110CrossRefGoogle Scholar
  31. MacLennan, I. C. M. (1973). Contemp. Top. Immunobiol., 2, 175CrossRefGoogle Scholar
  32. Makinodan, T., Santos, G. W. and Quinn, R. P. (1970). A. Pharmac. Rev., 22, 189Google Scholar
  33. Mantovani, A., Tagliabue, A., Vecchi, A. and Spreafico, F. (1976). Eur. J. Cancer, 12, 381CrossRefGoogle Scholar
  34. Mawas, C., Carey, T. and Mihich, E. (1973). Cell. Immun., 6, 243CrossRefGoogle Scholar
  35. Medzihradsky, J., Ehrke, J. and Mihich, E. (1977). Biochem. Pharmac., 26, 203CrossRefGoogle Scholar
  36. Mihich, E. (1963). Cancer Res., 23, 1375Google Scholar
  37. Mihich, E. (1965). Archivio Italiano di Patologia e Clinica Dei Tumori, 8, 153Google Scholar
  38. Mihich, E. (1971). In Prediction of Response in Cancer Chemotherapy and Immunity, (ed. T. C. Hall), NCI Monograph 34, U.S. Government Printing OfficeGoogle Scholar
  39. Mihich, E. (1975a). Transplant. Proc., 7, 275Google Scholar
  40. Mihich, E. (1975b) In Antineoplastic and Immunosuppressive Agents, (eds. A. Sartorelli and D. Johns), Springer-Verlag, New YorkGoogle Scholar
  41. Mihich, E. (1976). In Chemotherapy, (eds. K. Hellmann and T. A. Connors) Vol. 7, Plenum Publishing Corp. New YorkGoogle Scholar
  42. Mihich, E. (1978a). Monograph of First National Course of Chemotherapy of Solid Tumor, Bologna, Italy, (ed. F. Pannuti ), Editrice Universitaria Bolognese, pp. 143–180Google Scholar
  43. Mihich, E. (1978b). Proc. of 7th International Symposium on the Biological Characterization of Human Tumours, Budapest, Hungary, Excerpta Medica, Amsterdam, (in press)Google Scholar
  44. Mihich, E. and Grindey, G. (1977). Cancer, 40, 534CrossRefGoogle Scholar
  45. Mihich, E., Dave, C. and Williams-Ashman, H. G. (1974). In Proceeding 8th International Congress of Chemotherapy, (ed. G. K. Daikos) Vol. 3, 845Google Scholar
  46. Mihich, E., Laurence, D. J. R., Laurence, D. M. and Eckhardt, S. (1976). UICC Technical Rept., Vol. 21, GenevaGoogle Scholar
  47. Moran, R. G., Domin, B. A. and Zakrzewski, S. F. (1975). Proc. Am. Ass. Cancer Res., 16, 49Google Scholar
  48. Orsini, F., Pavelic, Z. and Mihich, E. (1977). Cancer Res., 37, 1719Google Scholar
  49. Pegg, A. E. (1973). Biochem. J., 132, 537CrossRefGoogle Scholar
  50. Pegg, A. E., Corti, A. and Williams-Ashman, H. G. (1973). Biochem. Biophys. Res. Commun., 52, 696CrossRefGoogle Scholar
  51. Perlmann, P. and Perlmann, H. (1970). Cell. Immun., 1, 300CrossRefGoogle Scholar
  52. Prehn, R. T. (1968). Cancer Res., 28, 1326Google Scholar
  53. Rustum, Y. M., Grindey, G. B., Hakala, M. T. and Mihich, E. (1976). In Advances in Enzyme Regulation, (ed. G. Weber) 14, Pergamon Press, New York and OxfordGoogle Scholar
  54. Schwartz, H. S. and Mihich, E. (1973). In Drug Resistance and Selectivity: Biochemical and Cellular Basis, (ed. E. Mihich), Academic Press, New YorkGoogle Scholar
  55. Swanson, M. A. and Schwartz, R. S. (1967). New Engl. J. Med., 277, 163CrossRefGoogle Scholar
  56. Turk, J. L. (1973). Proc. R. Soc. Med., 66, 805Google Scholar
  57. Uy, Q. L., Srinivasan, T., Santos, G. W. and Owens, A. H., Jr. (1966). Expl Hemat., 10, 4Google Scholar
  58. Weiss, D. W. (1969). Cancer Res., 29, 2368Google Scholar
  59. Werkheiser, W. C. (1961). J. biol. Chem., 236, 888Google Scholar
  60. Williams-Ashman, H. G. and Schenone, A. (1972). Biochim. Biophys. Res. Commun., 46, 288CrossRefGoogle Scholar
  61. Zakrzewski, S. F. and Nichol, C. A. (1958). Biochim. Biophys. Acta, 27, 425CrossRefGoogle Scholar

Copyright information

© Institute of Biology Endowment Trust Fund 1979

Authors and Affiliations

  • E. Mihich
    • 1
  1. 1.Department of Experimental Therapeutics and Grace Cancer Drug CenterRoswell Park Memorial Institute, New York State Department of HealthBuffaloUSA

Personalised recommendations